We are experts in the strategy, design, and implementation
of global early access programs
The Inceptua Medicines Access management team pioneered many of the support services which are now standard across the industry, including:
When patients have a life threatening or debilitating illness, their physicians have exhausted current treatment options or there simply aren’t any treatment options available or they are unable to enter a clinical trial, mechanisms exist across the globe to enable access to early access (pre-approval, managed access program, compassionate use program, expanded access program) or unlicensed medicines.
Healthcare professionals often seek to access these medicines for their patients and biopharmaceutical companies developing innovative medicines are increasingly making these medicines available to patients through an early access program and unlicensed medicines access programs.
WE HELP PATIENTS GET
ACCESS TO TREATMENT
WE RUN ACCESS PROGRAMS
CONSULTING SERVICES TO BIOTECH AND PHARMA
CONSULTING AND DELIVERY
The Inceptua Early Access management team pioneered many of the support services which are now standard across the industry:
At Inceptua we constantly strive to deliver value for our clients. We continually refine our offerings, based on client feedback, to ensure we maintain our position as the thought leader within this industry. Inceptua can support you whatever your need is, and we can create customized services to address your specific requirements.
If you are at the early stages of considering early access to one of your medicines, but aren’t quite ready to move ahead and engage with a vendor, then please take a look at our Ask Inceptua service, through which we commit to answering up to 10 questions you may have about early access, in a no-obligation setting.
We work with pharmaceutical and biotech companies of all sizes to design programs which meet global requirements. As a team of leading experts in pre-approval and unlicensed access to medicines, we design strategies and programs to meet your objectives, the requirements for each specific product and the needs of the patients who are to be treated.
Our programs are powered by an understanding of specific need and delivered with compassion for patients. We understand the importance of your clinical development program, and ensure that any access program implemented delivers for both patients and physicians.
We have experience in the implementation of early access programs for medicines still in clinical development, as well as unlicensed medicines access programs providing access to medicines post first approval in countries where they are not commercially available.
Ask our experts